From, Arthur H L <br/><br/>
Do engineered natriuretic peptides have greater therapeutic potential than do native peptides?  [electronic resource] 

 -  Cardiovascular research  Dec 2010 
 - 391-2 p.  digital 
<br/><br/> Publication Type: Editorial; Research Support, N.I.H., Extramural; Comment 
<br/><br/><label>ISSN: </label>1755-3245 
<br/><br/><label>Standard No.: </label>10.1093/cvr/cvq319  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Atrial Natriuretic Factor--therapeutic use<br/>Calcineurin--physiology<br/>Heart Failure--drug therapy<br/>Humans<br/>Hypertension--drug therapy<br/>Models, Animal<br/>Myocytes, Cardiac--drug effects<br/>Natriuretic Agents--therapeutic use<br/>Natriuretic Peptide, Brain--pharmacology<br/>Natriuretic Peptides--pharmacology<br/>Peptide Fragments--therapeutic use<br/>Rats<br/>Recombinant Fusion Proteins--pharmacology<br/>Signal Transduction--physiology<br/>Sodium-Hydrogen Exchangers--physiology<br/>Ventricular Remodeling--drug effects